Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Two Formulations of GSK Biologicals' Varicella Vaccine

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00568334
First received: December 5, 2007
Last updated: November 2, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 3, 2009
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):